SCHEMBL6700259

SCHEMBL6700259

CCOC(Cc1ccc(OC(C)c2nc3ccc(OC)cc3[nH]2)cc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 13/20 0.47
PPARG P37231 9/20 0.46
PPARD Q03181 8/20 0.46
MEN1 O00255 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP1A2 P05177 1/20 0.43
CYP2E1 P05181 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C8 P10632 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP7 P09237 1/20 0.42
EGLN1 Q9GZT9 1/20 0.41
BRS3 P32247 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6700575 0.99 PPARA (0.46) PPARAPPARGPPARDMEN1HTT
SCHEMBL6701366 0.91 MEN1 (0.44) MEN1HTTKMT2ACYP1A2CYP2E1
SCHEMBL6701349 0.85 EGLN1 (0.46) MEN1HTTKMT2ACYP1A2CYP2E1
Hydrochloric Acid SCHEMBL6715713 0.84 EGLN1 (0.45) MEN1HTTKMT2ACYP1A2CYP2E1
Hydrochloric Acid SCHEMBL6723932 0.84 TPH1 (0.47) MEN1HTTKMT2ACYP1A2CYP2E1
Hydrochloric Acid SCHEMBL6723945 0.84 TPH1 (0.47) MEN1HTTKMT2ACYP1A2CYP2E1
SCHEMBL6703939 0.83 CYP2E1 (0.46) MEN1HTTKMT2ACYP1A2CYP2E1
SCHEMBL6699638 0.83 MEN1 (0.45) MEN1HTTKMT2ACYP1A2CYP2E1
SCHEMBL6700569 0.83 CYP2E1 (0.43) MEN1HTTKMT2ACYP1A2CYP2E1
Hydrochloric Acid SCHEMBL6697817 0.83 CYP2E1 (0.46) MEN1HTTKMT2ACYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-01 US claimed
US-20030069294-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-04-10 US claimed
EP-1167357-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP claimed
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-01 US disclosed
US-6596751-B2 An insulin resistance improving agent, hypoglycemic agent, immunoregulatory agent, aldose reductase inhibitor, 5-lipoxygenase inhibitor, peroxidized lipid production suppressor, PPAR. activator, leukotriene antagonist, adipose SANKYO COMPANY LIMITED (JP) 2003-07-22 US disclosed
US-20030069294-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-04-10 US disclosed
EP-1167357-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SLC5A1, SLC2A1, GPR119 PPARA 216/4885PPARG 152/4885PPARD 377/4885
US-20030069294-A1 Alpha-substituted carboxylic acid derivatives SLC5A1, SLC2A1, GPR119 PPARA 216/4885PPARG 152/4885PPARD 377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.